Active14533667Private limited companySlough

BXTA NANOTHERAPY LTD

Significant control: Bxtaccelyon Limited (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Coming soon · product and service lists

What does Bxta Nanotherapy Ltd sell?

Registered activity: Specialists medical practice activities (SIC 86220). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

BXTA NANOTHERAPY LTD is an active private limited company (company number 14533667) incorporated on 9 December 2022, registered in Slough. Its registered activity is specialists medical practice activities (SIC 86220). Latest small accounts cover the period ending 30 June 2025, showing net assets of £335k and cash of £81k, with 4 employees on average. Net assets fell 9% on the prior period (£367k).

Peer position · net assets

By net assets it sits in the top quarter of 353 comparable companies in Reading (median £20k, upper quartile £119k).

02

Ownership and control

1 active
  • Bxtaccelyon Limited
    corporate entity, United Kingdom · since 9 December 2022
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
9 December 20223 yrs ago
Next accounts due
30 March 2027in 158 days
Confirmation statement due
23 December 2026in 61 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 86220
Specialists medical practice activities
Accounts type
Small
Size band
MicroCompanies Act thresholds
05

Financials

2 periods on record · latest ending 30 June 2025
Net assets
£335k
−9%vs Jun 2024
Cash at bank
£81k
−76%vs Jun 2024
Turnover
Not reported
Employees
4
No changevs Jun 2024
Net assets
£335k
Cash at bank
£81k
Average employees
4
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
30 June 2025£335k£81k—£140k——4
30 June 2024£367k£333k—£103k——4
Current ratio1.05Current assets ÷ creditors within one year
Cash per employee£20kCash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £335,093 at 30 June 2025
  • Cash at bank of £50,000 or moreCash £80,724
  • Incorporated two to five years agoIncorporated 9 December 2022

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Next accounts duein 158 days
  2. Confirmation statement duein 61 days
  3. Accounts period endNet assets £335k · small accounts
  4. Accounts period endNet assets £367k · small accounts
  5. Incorporated
08

Similar companies in Reading

Same activity (specialists medical practice activities), closest in incorporation date
09

Reminders for BXTA NANOTHERAPY LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.